Literature DB >> 3300534

Broth dilution testing of Candida albicans susceptibility to ketoconazole.

C E Hughes, R L Bennett, W H Beggs.   

Abstract

We performed a detailed investigation of the kinetics of ketoconazole activity in the setting of broth dilution testing of Candida albicans susceptibility. Turbidimetric readings reflected parallel quantitative colony counts. The method of endpoint determination markedly affected the results. Determinations of 50% inhibitory concentrations clearly separated the ketoconazole-resistant strains from the susceptible strains.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3300534      PMCID： PMC174798          DOI： 10.1128/AAC.31.4.643

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  12 in total

1.  Ketoconazole and the liver.

Authors:  C R Horseburgh; C H Kirkpatrick; C B Teutsch
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

2.  Inhibition and killing of Candida albicans in vitro by five imidazoles in clinical use.

Authors:  E Lefler; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

3.  In-vitro resistance to imidazole antifungals in Candida albicans.

Authors:  E M Johnson; M D Richardson; D W Warnock
Journal:  J Antimicrob Chemother       Date:  1984-06       Impact factor: 5.790

4.  Effects of pH on the activity of ketoconazole against Candida albicans.

Authors:  H Minagawa; K Kitaura; N Nakamizo
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

Review 5.  Antifungal drug susceptibility testing. A critical review.

Authors:  D A Stevens
Journal:  Mycopathologia       Date:  1984-09-30       Impact factor: 2.574

6.  Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.

Authors:  G V Doern; T A Tubert; K Chapin; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

7.  Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans.

Authors:  W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

8.  Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

Authors:  J N Galgiant; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

9.  Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size.

Authors:  J N Galgiani; D A Stevens
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

10.  Problems in the laboratory assessment of antifungal activity.

Authors:  F C Odds
Journal:  Postgrad Med J       Date:  1979-09       Impact factor: 2.401
View more
  10 in total

1.  In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method.

Authors:  M T Blanco; C Pérez-Giraldo; J Blanco; F J Morán; C Hurtado; A C Gómez-García
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

2.  Ketoconazole resistance in Torulopsis glabrata.

Authors:  G Nobre; E Mendes; M J Charrua; O Cruz
Journal:  Mycopathologia       Date:  1989-07       Impact factor: 2.574

Review 3.  Testing of organisms for susceptibility to triazoles: is it justified?

Authors:  G S Kobayashi; E D Spitzer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-05       Impact factor: 3.267

4.  Improved method for azole antifungal susceptibility testing.

Authors:  M A Gordon; E W Lapa; P G Passero
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

Review 5.  Carrier effects on biological activity of amphotericin B.

Authors:  J Brajtburg; J Bolard
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

6.  Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.

Authors:  I W Fong; R M Bannatyne; P Wong
Journal:  Genitourin Med       Date:  1993-02

7.  Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.

Authors:  C E Hughes; R L Bennett; I C Tuna; W H Beggs
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

8.  Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading.

Authors:  E Anaissie; V Paetznick; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

9.  Collaborative investigation of broth microdilution and semisolid agar dilution for in vitro susceptibility testing of Candida albicans.

Authors:  R Shawar; V Paetznick; Z Witte; L G Ensign; E Anaissie; M LaRocco
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

10.  Innovative endpoint determination system for antifungal susceptibility testing of yeasts.

Authors:  R Tellier; M Krajden; G A Grigoriew; I Campbell
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.